Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Tuberculosis | Research article

Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Introduction

Person-centred care, an internationally recognised priority, describes the involvement of people in their care and treatment decisions, and the consideration of their needs and priorities within service delivery. Clarity is required regarding how it may be implemented in practice within different contexts. The standard multi-drug resistant tuberculosis (MDR-TB) treatment regimen is lengthy, toxic and insufficiently effective. 2019 World Health Organisation guidelines include a shorter (9–11-month) regimen and recommend that people with MDR-TB be involved in the choice of treatment option. We examine the perspectives and experiences of people with MDR-TB and health-care workers (HCW) regarding person-centred care in an MDR-TB programme in Karakalpakstan, Uzbekistan, run by Médecins Sans Frontières and the Ministry of Health.

Methods

A qualitative study comprising 48 interviews with 24 people with MDR-TB and 20 HCW was conducted in June–July 2019. Participants were recruited purposively to include a range of treatment-taking experiences and professional positions. Interview data were analysed thematically using coding to identify emerging patterns, concepts, and categories relating to person-centred care, with Nvivo12.

Results

People with MDR-TB were unfamiliar with shared decision-making and felt uncomfortable taking responsibility for their treatment choice. HCW were viewed as having greater knowledge and expertise, and patients trusted HCW to act in their best interests, deferring the choice of appropriate treatment course to them. HCW had concerns about involving people in treatment choices, preferring that doctors made decisions. People with MDR-TB wanted to be involved in discussions about their treatment, and have their preference sought, and were comfortable choosing whether treatment was ambulatory or hospital-based. Participants felt it important that people with MDR-TB had knowledge and understanding about their treatment and disease, to foster their sense of preparedness and ownership for treatment. Involving people in their care was said to motivate sustained treatment-taking, and it appeared important to have evidence of treatment need and effect.

Conclusions

There is a preference for doctors choosing the treatment regimen, linked to shared decision-making unfamiliarity and practitioner-patient knowledge imbalance. Involving people in their care, through discussions, information, and preference-seeking could foster ownership and self-responsibility, supporting sustained engagement with treatment.
Literature
1.
go back to reference Pontali E, Raviglione MC, Migliori GB. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives. Eur Respir Rev. 2019;28(152):190035.PubMed Pontali E, Raviglione MC, Migliori GB. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives. Eur Respir Rev. 2019;28(152):190035.PubMed
2.
go back to reference World Health Organisation. Global Tuberculosis Report 2019. WHO: Geneva; 2019. World Health Organisation. Global Tuberculosis Report 2019. WHO: Geneva; 2019.
3.
go back to reference Silva DR, Dalcolmo M, Tiberi S, Arbex MA, Munoz-Torrico M, Duarte R, et al. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis. J Bras Pneumol. 2018;44(2):153–60.PubMedPubMedCentral Silva DR, Dalcolmo M, Tiberi S, Arbex MA, Munoz-Torrico M, Duarte R, et al. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis. J Bras Pneumol. 2018;44(2):153–60.PubMedPubMedCentral
4.
go back to reference Tiberi S, du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, et al. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis. 2018;18(7):E183–98.PubMed Tiberi S, du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, et al. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis. 2018;18(7):E183–98.PubMed
5.
go back to reference Lange C, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR. Management of drug-resistant tuberculosis. Lancet. 2019;394(10202):953–66.PubMed Lange C, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR. Management of drug-resistant tuberculosis. Lancet. 2019;394(10202):953–66.PubMed
8.
go back to reference Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, et al. Person-centered care - ready for prime time. Eur J Cardiovasc Nurs. 2011;10(4):248–51.PubMed Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, et al. Person-centered care - ready for prime time. Eur J Cardiovasc Nurs. 2011;10(4):248–51.PubMed
9.
go back to reference Olsson L-E, Ung EJ, Swedberg K, Ekman I. Efficacy of person-centred care as an intervention in controlled trials – a systematic review. J Clin Nurs. 2013;22(3–4):456–65.PubMed Olsson L-E, Ung EJ, Swedberg K, Ekman I. Efficacy of person-centred care as an intervention in controlled trials – a systematic review. J Clin Nurs. 2013;22(3–4):456–65.PubMed
10.
go back to reference Leplege A, Gzil F, Cammelli M, Lefeve C, Pachoud B, Ville I. Person-centredness: conceptual and historical perspectives. Disabil Rehabil. 2007;29(20–21):1555–65.PubMed Leplege A, Gzil F, Cammelli M, Lefeve C, Pachoud B, Ville I. Person-centredness: conceptual and historical perspectives. Disabil Rehabil. 2007;29(20–21):1555–65.PubMed
11.
go back to reference Pai M, Yadav P, Anupindi R. Tuberculosis control needs a complete and patient-centric solution. Lancet Glob Health. 2014;2(4):e189–90.PubMed Pai M, Yadav P, Anupindi R. Tuberculosis control needs a complete and patient-centric solution. Lancet Glob Health. 2014;2(4):e189–90.PubMed
14.
go back to reference Ahmedov M, Azimov R, Mutalova Z, Huseynov S, Tsoyi E, Rechel B. Uzbekistan: health system review. Health Syst Transit. 2014;16(5):1–137 xiii.PubMed Ahmedov M, Azimov R, Mutalova Z, Huseynov S, Tsoyi E, Rechel B. Uzbekistan: health system review. Health Syst Transit. 2014;16(5):1–137 xiii.PubMed
15.
go back to reference Mol A. The logic of care. Health and the problem of patient choice. Abingdon: Routledge; 2008. Mol A. The logic of care. Health and the problem of patient choice. Abingdon: Routledge; 2008.
16.
go back to reference Polak L. What is wrong with ‘being a pill-taker’? The special case of statins. Sociol Health Illn. 2017;39(4):599–613.PubMed Polak L. What is wrong with ‘being a pill-taker’? The special case of statins. Sociol Health Illn. 2017;39(4):599–613.PubMed
17.
go back to reference Beckmann N. Responding to medical crises: AIDS treatment, responsibilisation and the logic of choice. Anthropol Med. 2013;20(2):160–74.PubMed Beckmann N. Responding to medical crises: AIDS treatment, responsibilisation and the logic of choice. Anthropol Med. 2013;20(2):160–74.PubMed
18.
go back to reference Kawuma R, Seeley J, Mupambireyi Z, Cowan F, Bernays S. REALITY trial team. ‘Treatment is not yet necessary’: delays in seeking access to HIV treatment in Uganda and Zimbabwe. Afr J AIDS Res AJAR. 2018;17(3):217–25.PubMed Kawuma R, Seeley J, Mupambireyi Z, Cowan F, Bernays S. REALITY trial team. ‘Treatment is not yet necessary’: delays in seeking access to HIV treatment in Uganda and Zimbabwe. Afr J AIDS Res AJAR. 2018;17(3):217–25.PubMed
19.
go back to reference Cohen H, Britten N. Who decides about prostate cancer treatment? A qualitative study. Fam Pract. 2003;20(6):724–9.PubMed Cohen H, Britten N. Who decides about prostate cancer treatment? A qualitative study. Fam Pract. 2003;20(6):724–9.PubMed
20.
go back to reference Schildmann J, Ritter P, Salloch S, Uhl W, Vollmann J. ‘One also needs a bit of trust in the doctor … ’: a qualitative interview study with pancreatic cancer patients about their perceptions and views on information and treatment decision-making. Ann Oncol. 2013;24(9):2444–9.PubMed Schildmann J, Ritter P, Salloch S, Uhl W, Vollmann J. ‘One also needs a bit of trust in the doctor … ’: a qualitative interview study with pancreatic cancer patients about their perceptions and views on information and treatment decision-making. Ann Oncol. 2013;24(9):2444–9.PubMed
21.
go back to reference Parsons T. Illness and the role of the physician: a sociological perspective. Am J Orthop. 1951;21(3):452–60. Parsons T. Illness and the role of the physician: a sociological perspective. Am J Orthop. 1951;21(3):452–60.
22.
go back to reference Larson HJ, Clarke RM, Jarrett C, Eckersberger E, Levine Z, Schulz WS, et al. Measuring trust in vaccination: A systematic review. Hum Vaccines Immunother. 2018;14(7):1599–609. Larson HJ, Clarke RM, Jarrett C, Eckersberger E, Levine Z, Schulz WS, et al. Measuring trust in vaccination: A systematic review. Hum Vaccines Immunother. 2018;14(7):1599–609.
23.
go back to reference Hall MA, Dugan E, Zheng B, Mishra AK. Trust in physicians and medical institutions: what is it, can it be measured, and does it matter? Milbank Q. 2001;79(4):613–39 v.PubMedPubMedCentral Hall MA, Dugan E, Zheng B, Mishra AK. Trust in physicians and medical institutions: what is it, can it be measured, and does it matter? Milbank Q. 2001;79(4):613–39 v.PubMedPubMedCentral
24.
go back to reference Brigden G, Nyang’wa B-T, du Cros P, Varaine F, Hughes J, Rich M, et al. Principles for designing future regimens for multidrug-resistant tuberculosis. Bull World Health Organ. 2014;92(1):68–74.PubMed Brigden G, Nyang’wa B-T, du Cros P, Varaine F, Hughes J, Rich M, et al. Principles for designing future regimens for multidrug-resistant tuberculosis. Bull World Health Organ. 2014;92(1):68–74.PubMed
25.
go back to reference Silva D. Helping people share decision-making. London: The Health Foundation; 2012. [cited 2019 Sep 27]. Available from: www.health.org.uk/ publications/helping-people-share-decision-making. Silva D. Helping people share decision-making. London: The Health Foundation; 2012. [cited 2019 Sep 27]. Available from: www.​health.​org.​uk/​ publications/helping-people-share-decision-making.
27.
go back to reference Schulman-Green D, Jaser S, Martin F, Alonzo A, Grey M, McCorkle R, et al. Processes of self-management in chronic illness. J Nurs Scholarsh. 2012;44(2):136–44.PubMedPubMedCentral Schulman-Green D, Jaser S, Martin F, Alonzo A, Grey M, McCorkle R, et al. Processes of self-management in chronic illness. J Nurs Scholarsh. 2012;44(2):136–44.PubMedPubMedCentral
28.
go back to reference Horter S, Stringer B, Greig J, Amangeldiev A, Tillashaikhov MN, Parpieva N, et al. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan. BMC Infect Dis. 2016;16:362.PubMedPubMedCentral Horter S, Stringer B, Greig J, Amangeldiev A, Tillashaikhov MN, Parpieva N, et al. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan. BMC Infect Dis. 2016;16:362.PubMedPubMedCentral
29.
go back to reference Stringer B, Lowton K, Tillashaikhov M, Parpieva N, Ulmasova D, du Cros P, et al. ‘They prefer hidden treatment’: anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2016;20(8):1084–90. Stringer B, Lowton K, Tillashaikhov M, Parpieva N, Ulmasova D, du Cros P, et al. ‘They prefer hidden treatment’: anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2016;20(8):1084–90.
30.
go back to reference Kübler-Ross E. On death and dying. New York: Springer; 1969. Kübler-Ross E. On death and dying. New York: Springer; 1969.
31.
go back to reference Mohr E, Snyman L, Mbakaz Z, Caldwell J, DeAzevedo V, Kock Y, et al. “Life continues”: Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa. PLoS One. 2018;13(9):e0203888.PubMedPubMedCentral Mohr E, Snyman L, Mbakaz Z, Caldwell J, DeAzevedo V, Kock Y, et al. “Life continues”: Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa. PLoS One. 2018;13(9):e0203888.PubMedPubMedCentral
Metadata
Title
Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan
Publication date
01-12-2020
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05407-7

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue